Stay ahead of the curve with in-depth coverage of the latest breakthroughs, emerging trends, strategic developments, and transformative innovations shaping the future of healthcare, science, technology, and global business.
Announcement Sinopia Biosciences, Inc., a leading biotechnology company known for modernising novel therapeutics with the help of its exclusive LEADS® drug discovery platform, proudly declared th...
Announcement Co-Diagnostics, Inc., a leading molecular diagnostics company with a remarkable patented platform for the establishment of molecular diagnostics tests, today proudly announced that it ha...
Announcement GE Healthcare’s CEO Peter Arduini is molding a new chapter for the overall $20 billion in business gained over the year. GE Healthcare Technologies was first introduced as a standa...
Milestone CancerVax, Inc., a leading developer of a groundbreaking Universal Cancer Treatment Platform that treats cancer through the body’s immune system, revealed its year end overview, spotl...
Announcement Phio Pharmaceuticals Corp., a well-known clinical-level siRNA biopharmaceutical company discovering therapeutics with its exclusive INTASYL® gene mutation technology to treat cancer....
Announcement Trump has been in the limelight since its tariffs storm that shook the trading, healthcare and other sectors as well. Recently, Trump has come up with some favourable and convincing deal...
FDA’s Policy Initiatives The FDA’s guidance and various policies were at a pace this year. Neverthless the guidance on vaccines and rare disease have attracted most of the deals, with pol...
Announcement Telo Genomics Corp., a champion in prognostic and diagnostic innovation fueled by advanced telomere analytics, has declared its new efforts for a new multiple myeloma (MM) Minimal Residu...
Announcement Xoma Royalty, a company that has been quietly building a business by acquiring troubled biotech firms, has found its latest target. Late Monday, Xoma announced plans to acquire Generatio...
Announcement Pharmanovia, a leading popular pharmaceutical company that markets the novel speciality drugs and the trusted developed medicines, has now introduced its Korjuny (Catumaxomab) in Germany...
Speak with a healthcare analyst about your research, consulting, or platform needs.